Evogene Ltd., a leading biotechnology company headquartered in Israel, focuses on the development of innovative solutions for the agriculture and pharmaceutical industries. Founded in 2002, Evogene has made significant strides in leveraging computational biology to enhance crop productivity and resilience, positioning itself as a pioneer in the field. The company’s core offerings include advanced seed traits and microbial products that improve plant health and yield. What sets Evogene apart is its unique integration of big data and machine learning, enabling the identification of novel genes and pathways for crop enhancement. With a strong market presence, Evogene has achieved notable milestones, including strategic partnerships and successful product launches, solidifying its reputation as a key player in the biotechnology sector.
How does Evogene Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Evogene Ltd.'s score of 23 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Evogene Ltd., headquartered in Israel (IL), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges available from the company. This lack of data suggests that Evogene may not have established formal commitments to reduce its carbon footprint or may not be publicly disclosing such information at this time. In the context of the industry, many companies are increasingly adopting science-based targets and sustainability initiatives to address climate change. However, without specific emissions data or commitments, it is unclear how Evogene aligns with these industry standards. As the company progresses, it may consider implementing measurable climate strategies to enhance transparency and contribute to global climate goals.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Evogene Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
